Search Press releases Keywords From To 9 Sep 2020 Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances Read More 4 Sep 2020 Disposals of own shares Read More 31 Aug 2020 Phase 3 data on VIMPAT[®] (lacosamide) in primary generalized tonic-clonic seizures published in Journal of Neurology, Neurosurgery & Psychiatry Read More 28 Aug 2020 Disposals of own shares Read More 21 Aug 2020 Disposals of own shares Read More 10 Aug 2020 Acquisitions and disposals of own shares Read More Pagination First page Previous page Previous … Page 53 Page 54 Page 55 Page 56 Current page 57 Page 58 Page 59 Page 60 Page 61 … Page 57 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
